140 related articles for article (PubMed ID: 28155963)
1. Stereoisomers of oseltamivir - synthesis, in silico prediction and biological evaluation.
Hajzer V; Fišera R; Latika A; Durmis J; Kollár J; Frecer V; Tučeková Z; Miertuš S; Kostolanský F; Varečková E; Šebesta R
Org Biomol Chem; 2017 Feb; 15(8):1828-1841. PubMed ID: 28155963
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel "Dual-site" binding oseltamivir derivatives as potent influenza virus neuraminidase inhibitors.
Ai W; Zhang J; Zalloum WA; Jia R; Cherukupalli S; Ding X; Sun Z; Sun L; Jiang X; Ma X; Li Z; Wang D; Huang B; Zhan P; Liu X
Eur J Med Chem; 2020 Apr; 191():112147. PubMed ID: 32092589
[TBL] [Abstract][Full Text] [Related]
3. Different synthetic strategies of oseltamivir phosphate: a potent influenza neuraminidase inhibitor.
Gong J; Xu W
Curr Med Chem; 2008; 15(30):3145-59. PubMed ID: 19075659
[TBL] [Abstract][Full Text] [Related]
4. Discovery of hydrazide-containing oseltamivir analogues as potent inhibitors of influenza A neuraminidase.
Zhao H; Jiang S; Ye Z; Zhu H; Hu B; Meng P; Hu Y; Zhang H; Wang K; Wang J; Tian Y
Eur J Med Chem; 2021 Oct; 221():113567. PubMed ID: 34082224
[TBL] [Abstract][Full Text] [Related]
5. Novel N-Substituted oseltamivir derivatives as potent influenza neuraminidase inhibitors: Design, synthesis, biological evaluation, ADME prediction and molecular docking studies.
Ye J; Yang X; Xu M; Chan PK; Ma C
Eur J Med Chem; 2019 Nov; 182():111635. PubMed ID: 31493744
[TBL] [Abstract][Full Text] [Related]
6. Discovery of C-1 modified oseltamivir derivatives as potent influenza neuraminidase inhibitors.
Ju H; Zhang J; Sun Z; Huang Z; Qi W; Huang B; Zhan P; Liu X
Eur J Med Chem; 2018 Feb; 146():220-231. PubMed ID: 29407952
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro study of novel neuraminidase inhibitors against avian influenza virus.
Kongkamnerd J; Cappelletti L; Prandi A; Seneci P; Rungrotmongkol T; Jongaroonngamsang N; Rojsitthisak P; Frecer V; Milani A; Cattoli G; Terregino C; Capua I; Beneduce L; Gallotta A; Pengo P; Fassina G; Miertus S; De-Eknamkul W
Bioorg Med Chem; 2012 Mar; 20(6):2152-7. PubMed ID: 22342267
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of NH
Wang K; Yang F; Wang L; Liu K; Sun L; Lin B; Hu Y; Wang B; Cheng M; Tian Y
Eur J Med Chem; 2017 Dec; 141():648-656. PubMed ID: 29107426
[TBL] [Abstract][Full Text] [Related]
9. Oseltamivir hydroxamate and acyl sulfonamide derivatives as influenza neuraminidase inhibitors.
Hong BT; Chen CL; Fang JM; Tsai KC; Wang SY; Huang WI; Cheng YE; Wong CH
Bioorg Med Chem; 2014 Dec; 22(23):6647-6654. PubMed ID: 25456388
[TBL] [Abstract][Full Text] [Related]
10. Discovery of highly potent and selective influenza virus neuraminidase inhibitors targeting 150-cavity.
Jia R; Zhang J; Bertagnin C; Cherukupalli S; Ai W; Ding X; Li Z; Zhang J; Ju H; Ma X; Loregian A; Huang B; Zhan P; Liu X
Eur J Med Chem; 2021 Feb; 212():113097. PubMed ID: 33385836
[TBL] [Abstract][Full Text] [Related]
11. High-yielding synthesis of the anti-influenza neuraminidase inhibitor (-)-oseltamivir by two "one-pot" sequences.
Ishikawa H; Suzuki T; Orita H; Uchimaru T; Hayashi Y
Chemistry; 2010 Nov; 16(42):12616-26. PubMed ID: 20859964
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of tamiflu and its phosphonate congeners possessing potent anti-influenza activity.
Shie JJ; Fang JM; Wang SY; Tsai KC; Cheng YS; Yang AS; Hsiao SC; Su CY; Wong CH
J Am Chem Soc; 2007 Oct; 129(39):11892-3. PubMed ID: 17850083
[No Abstract] [Full Text] [Related]
13. Synthesis and Biological Evaluation of
Hu Y; Chen B; Lei Z; Zhao H; Zhu H; Quan P; Tian Y
Molecules; 2019 Jun; 24(11):. PubMed ID: 31185617
[TBL] [Abstract][Full Text] [Related]
14. Structure-Based Optimization of N-Substituted Oseltamivir Derivatives as Potent Anti-Influenza A Virus Agents with Significantly Improved Potency against Oseltamivir-Resistant N1-H274Y Variant.
Zhang J; Murugan NA; Tian Y; Bertagnin C; Fang Z; Kang D; Kong X; Jia H; Sun Z; Jia R; Gao P; Poongavanam V; Loregian A; Xu W; Ma X; Ding X; Huang B; Zhan P; Liu X
J Med Chem; 2018 Nov; 61(22):9976-9999. PubMed ID: 30365885
[TBL] [Abstract][Full Text] [Related]
15. Divalent oseltamivir analogues as potent influenza neuraminidase inhibitors.
Yan ZL; Liu AY; Wei XX; Zhang Z; Qin L; Yu Q; Yu P; Lu K; Yang Y
Carbohydr Res; 2019 May; 477():32-38. PubMed ID: 30954773
[TBL] [Abstract][Full Text] [Related]
16. Efficient synthesis of highly active phospha-isosteres of the influenza neuraminidase inhibitor oseltamivir.
Carbain B; Collins PJ; Callum L; Martin SR; Hay AJ; McCauley J; Streicher H
ChemMedChem; 2009 Mar; 4(3):335-7. PubMed ID: 19156651
[TBL] [Abstract][Full Text] [Related]
17. Design, in silico studies, synthesis and in vitro evaluation of oseltamivir derivatives as inhibitors of neuraminidase from influenza A virus H1N1.
Neri-Bazán RM; García-Machorro J; Méndez-Luna D; Tolentino-López LE; Martínez-Ramos F; Padilla-Martínez II; Aguilar-Faisal L; Soriano-Ursúa MA; Trujillo-Ferrara JG; Fragoso-Vázquez MJ; Barrón BL; Correa-Basurto J
Eur J Med Chem; 2017 Mar; 128():154-167. PubMed ID: 28182988
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, structure and inhibitory activity of a stereoisomer of oseltamivir carboxylate.
Sartori A; Dell'Amico L; Battistini L; Curti C; Rivara S; Pala D; Kerry PS; Pelosi G; Casiraghi G; Rassu G; Zanardi F
Org Biomol Chem; 2014 Mar; 12(10):1561-9. PubMed ID: 24425043
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of "Multi-Site"-binding influenza virus neuraminidase inhibitors.
Jia R; Zhang J; Ai W; Ding X; Desta S; Sun L; Sun Z; Ma X; Li Z; Wang D; Huang B; Zhan P; Liu X
Eur J Med Chem; 2019 Sep; 178():64-80. PubMed ID: 31176096
[TBL] [Abstract][Full Text] [Related]
20. Development of a concise synthesis of (-)-oseltamivir (Tamiflu).
Trost BM; Zhang T
Chemistry; 2011 Mar; 17(13):3630-43. PubMed ID: 21365707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
